Abstract
The increase in the level of quinolone resistance of Haemophilus influenzae clinical isolates during ofloxacin therapy of a patient with recurrent respiratory infections was investigated. The first isolate (MIC of ciprofloxacin of 2 microg/ml) and the second isolate (MIC of 32 microg/ml) belonged to the same clone, as shown by pulsed-field gel electrophoresis, and the increase in the resistance level was associated with a substitution in Ser-84 to Arg in the ParC protein. These results emphasize the potential risk of development of quinolone-resistant H. influenzae during fluoroquinolone therapy in patients with recurrent respiratory infection.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Substitution
-
Anti-Infective Agents / pharmacology*
-
Anti-Infective Agents / therapeutic use
-
DNA Topoisomerase IV
-
DNA Topoisomerases, Type II / genetics
-
DNA Topoisomerases, Type II / metabolism
-
Female
-
Haemophilus Infections / drug therapy
-
Haemophilus Infections / genetics
-
Haemophilus Infections / microbiology*
-
Haemophilus influenzae / drug effects*
-
Haemophilus influenzae / isolation & purification
-
Haemophilus influenzae / metabolism
-
Humans
-
Microbial Sensitivity Tests
-
Middle Aged
-
Mutation
-
Ofloxacin / pharmacology*
-
Ofloxacin / therapeutic use
-
Polymerase Chain Reaction
-
Recurrence
-
Respiratory Tract Infections / drug therapy
-
Respiratory Tract Infections / microbiology*
Substances
-
Anti-Infective Agents
-
Ofloxacin
-
DNA Topoisomerase IV
-
DNA Topoisomerases, Type II